X @The Economist

Until recently, Indians had few safe ways of joining the global craze for weight-loss drugs. But as patents for the active ingredient in Ozempic and Wegovy expire, the country’s generics giants could make slimming cheaper worldwide https://t.co/Wn1jDFfF0U ...